Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 45555 

EIS No. 20110235, Draft EIS, DOE, WA, 

Klickitat Hatchery Complex Program, 

Proposed Changes to Production 

Programs for Four Anadromous Fish 

Species, Klictitat River Subbasin, 

Klickitat and Yakima Counties, WA, 

Comment Period Ends: 09/12/2011, 

Contact: Hannah Dondy-Kaplan 503– 

230–4071. 

EIS No. 20110236, Draft EIS, FTA, GA, 

Tier 1—Atlanta Beltline City of 

Atlanta, Proposed Fixed Guideway 

Transit and Multi-Use Trails System, 

Right-of-Way Preservation, Fulton 

County, GA, Comment Period Ends: 

09/12/2011, Contact: Keith Melton 

404–865–5600. 

EIS No. 20110237, Final EIS, BLM, WY, 

Buckskin Mine Hay Creek II Project, 

Coal Lease Application WYW– 

172684, Wyoming Powder River 

Basin, Campbell County, WY, Review 

Period Ends: 08/29/2011, Contact: 

Teresa Johnson 307–261–7510. 

EIS No. 20110238, Draft EIS, NPS, DC, 

Anacostia Park Wetland and Resident 

Goose Management Plan, To Guide 

and Direct the Actions of National 

Park Service (NPS) in the 

Management of Wetlands and 

Resident (non-migratory) Canada 

Geese at Anacostia Park, 

Implementation, Washington, DC, 

Comment Period Ends: 09/26/2011, 

Contact: Alex Romero 202–690–5197. 

EIS No. 20110239, Draft EIS, BLM, 00, 

Gateway West Transmission Line 

Project, Proposed To Analyze the 

Effects of Authorizing the Proponents 

(Rocky Mountain Power and Idaho 

Power) to Construct and Operate the 

Gateway West Transmission Line 

Project, Application for Right-of-Way 

(ROW) Grants to Utilize Portions of 

National System of Public Lands and 

Special Use Permits to Utilize 

Portions of National Forest System 

Lands in Southern Wyoming, 

Southern Idaho and Possibly Northern 

Nevada, Comment Period Ends: 10/ 

26/2011, Contact: Walter E. George 

307–775–6116. 

EIS No. 20110240, Draft EIS, NPS, AK, 

Denali Park Road and Preserve, Draft 

Vehicle Management Plan, 

Implementation, AK, Comment Period 

Ends: 09/30/2011, Contact: Miriam 

Valentine 907–733–9102. 

EIS No. 20110241, Draft EIS, NNSA, 

NV, Site-Wide EIS—Continued 

Operation of the Department of 

Energy/National Nuclear Security 

Administration, Nevada National 

Security Site and Off-Site Location in 

Nevada, Comment Period Ends: 10/ 

27/2011, Contact: Linda M. Cohn 

702–295–0077. 

EIS No. 20110242, Final EIS, BLM, CO, 

Over The River (OTR) Project, 

Propose to Install a Temporary Work 

of Art, Require the Use of Federal, 

Private and State Lands Adjacent to 

the River, Western Fremont County 

and Southeast Portion of Chaffee 

County, CO, Review Period Ends: 08/ 

29/2011, Contact: Vincent Hopper 

719–269–8555. 

EIS No. 20110243, Draft EIS, FHWA, 00, 

Tier 1—National Highway System 

(NHS) Corridor, Propose to Develop 

an Improved Transportation 

Connecting (US–220) between I–68 

and Corridor H, Grant, Hardy, 

Hampshire, Mineral Counties, WV 

and Allegany County, MD, Comment 

Period Ends: 10/14/2011, Contact: 

Greg Bailey 304–558–9722. 

EIS No. 20110244, Draft EIS, FHWA, 

OR, US–97 Bend North Corridor 

Project, Propose to Improve a Segment 

of US–97 in Deschutes County, 

Oregon between the Deschutes Market 

Road/Tumalo Junction Interchange 

and the Empire Avenue Interchange, 

Deschutes County, OR, Comment 

Period Ends: 09/12/2011, Contact: 

Chris Bucher 503–399–5749. 

Amended Notices 

EIS No. 20110225, Final EIS, FHWA, 

TN, Interstate 55 Interchange at E.H. 

Crump Boulevard and South 

Boulevard Project, To Provide a 

Balanced Solution for Safety and 

Capacity Issues at the I55 Interchange, 

City of Memphis, Shelby County, TN, 

Review Period Ends: 08/22/2011, 

Contact: Charles J. O’Neill 615–781– 

5772. 

Review to FR Notice 07/22/2011: 

Correction to Review Period End from 

08/15/2011 to 08/22/2011. 

EIS No. 20110228, Final EIS, FHWA, IN, 

I–69 Evansville to Indianapolis Tier 2 

Section 4 Project, From U.S. 231 

(Crane NSWC) to IN–37 South of 

Bloomington in Section 4, Greene and 

Monroe Counties, IN, Review Period 

Ends: 08/22/2011, Contact: Michelle 

Allen 317–226–7344. 

Review to FR Notice 07/22/2011: 

Correction to Review Period End from 

08/15/2011 to 08/22/2011. 

EIS No. 20110231, Final EIS, BLM, NV, 

Salt Wells Energy Projects, Proposal 

for Three Separate Geothermal Energy 

and Transmission Projects, 

Implementation, Churchill County, 

NV, Review Period Ends: 08/22/2011, 

Contact: Colleen Sievers 775–885– 

6168. 

Review to FR Notice 07/22/2011: 

Correction to Review Period End from 

08/15/2011 to 08/22/2011. 

EIS No. 20110234, Final EIS, FHWA, WI, 

US 41 Improvement Project, Extend 

from Depere—Suamico (Memorial 

Drive to County M), Brown County, 

WI, Review Period Ends: 08/22/2011, 

Contact: George Poirier 608–829– 

7500. 

Review to FR Notice 07/22/2011: 

Correction to Review Period End from 

08/15/2011 to 08/22/2011. 

Dated: July 26, 2011. 

Cliff Rader, 

Acting Director, NEPA Compliance Division, 

Office of Federal Activities. 

[FR Doc. 2011–19234 Filed 7–28–11; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2011–0550; FRL–8882–2] 

Nominations to the FIFRA Scientific 

Advisory Panel; Request for 

Comments 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This notice provides the 

names, addresses, professional 

affiliations, and selected biographical 

data of persons nominated to serve on 

the Scientific Advisory Panel (SAP) 

established under section 25(d) of the 

Federal Insecticide, Fungicide, and 

Rodenticide Act (FIFRA). The Panel was 

created on November 28, 1975, and 

made a statutory Panel by amendment 

to FIFRA, dated October 25, 1988. The 

Agency, at this time, anticipates 

selecting two new members to serve on 

the panel as a result of membership 

terms that will expire next year. Public 

comments on the nominations are 

invited, as these comments will be used 

to assist the Agency in selecting the new 

chartered Panel members. 

DATES: Comments, identified by docket 

ID number EPA–HQ–OPP–2011–0550, 

must be received on or before August 

29, 2011. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPP–2011–0550, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the on-line 

instructions for submitting comments. 

• Mail: Office of Pesticide Programs 

(OPP) Regulatory Public Docket (7502P), 

Environmental Protection Agency, 1200 

Pennsylvania Ave., NW., Washington, 

DC 20460–0001. 

• Delivery: OPP Regulatory Public 

Docket (7502P), Environmental 

Protection Agency, Rm. S–4400, One 

Potomac Yard (South Bldg.), 2777 S. 

Crystal Dr., Arlington, VA. Deliveries 

are only accepted during the Docket 

Facility’s normal hours of operation 

mstockstill on DSK4VPTVN1PROD with NOTICES

45556 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 

(8:30 a.m. to 4 p.m., Monday through 

Friday, excluding legal holidays). 

Special arrangements should be made 

for deliveries of boxed information. The 

Docket Facility telephone number is 

(703) 305–5805. 

Instructions. Direct your comments to 

docket ID number EPA–HQ–OPP–2011– 

0550. If your comments contain any 

information that you consider to be CBI 

or otherwise protected, please contact 

the Designated Federal Official (DFO) 

listed under FOR FURTHER INFORMATION

CONTACT to obtain special instructions 

before submitting your comments. 

EPA’s policy is that all comments 

received will be included in the docket 

without change and may be made 

available on-line at http:// 

www.regulations.gov, including any 

personal information provided, unless 

the comment includes information 

claimed to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Do not submit information that you 

consider to be CBI or otherwise 

protected through regulations.gov or email. The regulations.gov Web site is an 

‘‘anonymous access’’ system, which 

means EPA will not know your identity 

or contact information unless you 

provide it in the body of your comment. 

If you send an e-mail comment directly 

to EPA without going through 

regulations.gov, your e-mail address 

will be automatically captured and 

included as part of the comment that is 

placed in the docket and made available 

on the Internet. If you submit an 

electronic comment, EPA recommends 

that you include your name and other 

contact information in the body of your 

comment and with any disk or CD–ROM 

you submit. If EPA cannot read your 

comment due to technical difficulties 

and cannot contact you for clarification, 

EPA may not be able to consider your 

comment. Electronic files should avoid 

the use of special characters, any form 

of encryption, and be free of any defects 

or viruses. 

Docket: All documents in the docket 

are listed in the docket index available 

at http://www.regulations.gov. Although 

listed in the index, some information is 

not publicly available, e.g., CBI or other 

information whose disclosure is 

restricted by statute. Certain other 

material, such as copyrighted material, 

is not placed on the Internet and will be 

publicly available only in hard copy 

form. Publicly available docket 

materials are available either in the 

electronic docket at http:// 

www.regulations.gov, or, if only 

available in hard copy, at the OPP 

Regulatory Public Docket in Rm. S– 

4400, One Potomac Yard (South Bldg.), 

2777 S. Crystal Dr., Arlington, VA. The 

hours of operation of this Docket 

Facility are from 8:30 a.m. to 4 p.m., 

Monday through Friday, excluding legal 

holidays. The Docket Facility telephone 

number is (703) 305–5805. 

FOR FURTHER INFORMATION CONTACT: 

Joseph E. Bailey, DFO, Office of Science 

Coordination and Policy (7201M), 

Environmental Protection Agency, 1200 

Pennsylvania Ave., NW., Washington, 

DC 20460–0001; telephone number: 

(202) 564–2045; fax number: (202) 564– 

8382; e-mail address: 

bailey.joseph@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. This action may, however, be 

of interest to persons who are or may be 

required to conduct testing of chemical 

substances under the Federal Food, 

Drug, and Cosmetic Act (FFDCA), 

FIFRA, and the Food Quality Protection 

Act of 1996 (FQPA). Since other entities 

may also be interested, the Agency has 

not attempted to describe all the specific 

entities that may be affected by this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the DFO 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

When submitting comments, 

remember to: 

1. Identify the document by docket ID 

number and other identifying 

information (subject heading, Federal 

Register date and page number). 

2. Follow directions. The Agency may 

ask you to respond to specific questions 

or organize comments by referencing a 

Code of Federal Regulations (CFR) part 

or section number. 

3. Explain why you agree or disagree; 

suggest alternatives and substitute 

language for your requested changes. 

4. Describe any assumptions and 

provide any technical information and/ 

or data that you used. 

5. If you estimate potential costs or 

burdens, explain how you arrived at 

your estimate in sufficient detail to 

allow for it to be reproduced. 

6. Provide specific examples to 

illustrate your concerns and suggest 

alternatives. 

7. Explain your views as clearly as 

possible, avoiding the use of profanity 

or personal threats. 

8. Make sure to submit your 

comments by the comment period 

deadline identified. 

II. Background 

The FIFRA SAP serves as the primary 

scientific peer review mechanism of 

EPA’s Office of Chemical Safety and 

Pollution Prevention (OCSPP) and is 

structured to provide scientific advice, 

information and recommendations to 

the EPA Administrator on pesticides 

and pesticide-related issues as to the 

impact of regulatory actions on health 

and the environment. The FIFRA SAP is 

a Federal advisory committee, 

established in 1975 under FIFRA, that 

operates in accordance with 

requirements of the Federal Advisory 

Committee Act (FACA). The FIFRA SAP 

is composed of a permanent panel 

consisting of seven members who are 

appointed by the EPA Administrator 

from nominees provided by the National 

Institutes of Health (NIH) and the 

National Science Foundation (NSF). 

FIFRA, as amended by FQPA, 

established a Science Review Board 

consisting of at least 60 scientists who 

are available to the SAP on an ad hoc 

basis to assist in reviews conducted by 

the FIFRA SAP. As a peer review 

mechanism, the FIFRA SAP provides 

comments, evaluations and 

recommendations to improve the 

effectiveness and quality of analyses 

made by Agency scientists. Members of 

the FIFRA SAP are scientists who have 

sufficient professional qualifications, 

including training and experience, to 

provide expert advice and 

recommendation to the Agency. 

In accordance with the statute, the 

SAP is composed of a permanent panel 

of seven members, selected and 

appointed by the Administrator of EPA 

from nominees submitted by both the 

NSF and the NIH. The Agency, at this 

time, anticipates selecting two new 

members to serve on the panel as a 

result of membership terms that will 

expire next year. The Agency requested 

nominations of experts to be selected 

from the fields of pharmacology, 

immunotoxicology, toxicology risk 

assessment, environmental toxicology 

and/or biostatistics with demonstrated 

experience and expertise in all phases of 

the risk assessment process including: 

Planning, scoping, and problem 

formulation; analysis; and interpretation 

and risk characterization (including the 

interpretation and communication of 

uncertainty). Nominees should be well 

published and current in their field of 

expertise. The statute further stipulates 

that we publish the name, address and 

professional affiliation in the Federal 

Register. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 45557 

III. Charter 

A Charter for the FIFRA SAP dated 

October 22, 2010, was issued in 

accordance with the requirements of the 

Federal Advisory Committee Act, Public 

Law 92–463, 86 Stat. 770 (5 U.S.C. App. 

I). 

A. Qualifications of Members 

Members are scientists who have 

sufficient professional qualifications, 

including training and experience, to be 

capable of providing expert comments 

as to the impact of pesticides on health 

and the environment. No persons shall 

be ineligible to serve on the Panel by 

reason of their membership on any other 

advisory committee to a Federal 

department or agency or their 

employment by a Federal department or 

agency (except the EPA). The Deputy 

Administrator appoints individuals to 

serve on the Panel for staggered terms of 

4 years. Panel members are subject to 

the provisions of 40 CFR part 3, subpart 

F, Standards of Conduct for Special 

Government Employees, which include 

rules regarding conflicts of interest. 

Each nominee selected by the Deputy 

Administrator, before being formally 

appointed, is required to submit a 

confidential statement of employment 

and financial interests, which shall fully 

disclose, among other financial 

interests, the nominee’s sources of 

research support, if any. 

In accordance with section 25(d)(1) of 

FIFRA, the Deputy Administrator shall 

require all nominees to the Panel to 

furnish information concerning their 

professional qualifications, educational 

background, employment history, and 

scientific publications. 

B. Applicability of Existing Regulations 

With respect to the requirements of 

section 25(d) of FIFRA that the 

Administrator promulgate regulations 

regarding conflicts of interest, the 

Charter provides that EPA’s existing 

regulations applicable to Special 

Government Employees, which include 

advisory committee members, will 

apply to the members of the SAP. These 

regulations appear in 40 CFR part 3, 

subpart F. In addition, the Charter 

provides for open meetings with 

opportunities for public participation. 

C. Process of Obtaining Nominees 

In accordance with the provisions of 

section 25(d) of FIFRA, EPA, on 

February 24, 2011, requested that the 

NIH and the NSF nominate scientists to 

fill vacancies occurring on the Panel. 

The Agency requested nominations of 

experts in the fields of pharmacology, 

immunotoxicology, toxicology risk 

assessment, environmental toxicology 

and/or biostatistics with demonstrated 

experience and expertise in all phases of 

the risk assessment process including: 

Planning, scoping, and problem 

formulation; analysis; and interpretation 

and risk characterization (including the 

interpretation and communication of 

uncertainty). NIH and NSF responded 

by letter, providing the Agency with a 

total of 38 nominees. Copies of these 

letters, with the listed nominees, are 

available in the public docket 

referenced in Unit I.B.1., of this notice. 

Of the 38 nominees, 20 are interested 

and available to actively participate in 

SAP meetings (see Unit IV. Nominees). 

The following 18 nominees are not 

available: 

1. Kim Boekelheide, PhD, Brown 

University, Providence, RI. 

2. Paul W. Brandt-Rauf, DrPH, MD, 

ScD, University of Illinois, Chicago, IL. 

3. Patricia A. Buffler, PhD, MPH, 

University of California, Berkeley, CA. 

4. John Cashman, PhD, Human 

Biomolecular Research Institute, San 

Diego, CA. 

5. Deborah A. Cory-Slechta, PhD, 

University of Rochester School of 

Medicine & Dentistry, Rochester, NY. 

6. Carlos Davidson, PhD, San 

Francisco State University, San 

Francisco, CA. 

7. Elaine Faustman, PhD, University 

of Washington, Seattle, WA. 

8. Clement Furlong, PhD, University 

of Washington, Seattle, WA. 

9. John P. Giesy, PhD, University of 

Sasketchewan, Saskatoon, 

Saskatchewan, Canada. 

10. Anumantha Kanthasamy, PhD, 

Iowa State University, Ames, IA. 

11. Stephen A. McCurdy, M.D., 

M.P.H., University of California-Davis, 

Davis, CA. 

12. Marie Lynn Miranda, PhD, Duke 

University, Durham, NC. 

13. James J. Pestka, PhD, Michigan 

State University, East Lansing, MI. 

14. Walter J. Rogan, M.D., National 

Institute of Environmental Health 

Sciences, Research Triangle Park, NC . 

15. Jason Rohr, PhD, University of 

South Florida, Tampa, FL. 

16. Anthony Scialli, M.D., Tetra Tech 

Services, Arlington, VA. 

17. Lester G. Sultatos, PhD, University 

of Medicine & Dentistry of New Jersey, 

Newark, NJ. 

18. Stephen C. Waring, DVM, PhD, 

Marshfield Clinic Research Foundation, 

Marshfield, WI. 

IV. Nominees 

The following are the names, 

addresses, professional affiliations, and 

selected biographical data of nominees 

being considered for membership on the 

FIFRA SAP. The Agency anticipates 

selecting two of the nominees to fill 

vacancies occurring next year. 

1. Daniel W. Anderson, PhD, 

University of California Davis, Davis, 

CA. 

i. Expertise: Ecotoxicology. 

ii. Education: B.S., in Zoology from 

North Dakota State University; M.S., in 

Wildlife Ecology and PhD, in Wildlife 

Ecology and Zoology from University of 

Wisconsin. 

iii. Professional Experience: Dr. 

Daniel Anderson is Professor Emeritus 

at the University of California Davis, 

where he was Director and co-founder 

of the Marine Bird Ecology and 

Ecotoxicology Project, and former Chair 

of the UC Davis Department of Wildlife, 

Fish, and Conservation Biology. He 

joined the faculty of UC Davis in 1976, 

and is continuing his research efforts on 

environmental contaminants and their 

effects on seabird populations, ecology, 

habitat, migration and related areas. 

While at UC Davis, he taught 

undergraduate courses in Wildlife 

Ecotoxicology, Avian Biology, and Field 

Biology Techniques; as well as graduate 

seminars in Ecotoxicology and Avian 

Ecology, and also served as founder and 

Chairperson of the Ecotoxicology ‘‘area 

of emphasis’’ in the Ecology Graduate 

Group at UC Davis. Prior to that, while 

at University of Wisconsin, he was 

instrumental in hypothesizing and 

documenting a specific link between the 

DDT-metabolite, DDE, and widespread 

eggshell thinning in susceptible species 

of birds. In late 1970, Dr. Anderson 

served as a Research Biologist for the 

U.S. Fish and Wildlife Service, working 

on pesticide contaminants in wildlife of 

California and Mexico, primarily to 

study and document contaminant 

changes in seabirds and raptors, in 

particular, the decline of DDE and 

associated beginnings of the recovery of 

the Brown Pelican. Dr. Anderson and 

his co-workers also published papers on 

the dynamics and effects of agricultural 

contaminants in migratory waterbirds. 

Dr. Anderson retired from teaching and 

administration in 2009, but continues 

his life-long commitment to 

ecotoxicology, seabird biology, and 

conservation. Dr. Anderson’s current 

research involves studies of 

contamination effects, distribution, and 

dynamics of organic and inorganic 

materials in birds from California and 

Baja California coastal and wetland 

environments. Dr. Anderson is also 

actively involved in the conservation 

and management of avian populations 

and their habitats. 

2. John C. Bailar, III, M.D., PhD, The 

University of Chicago, Chicago, IL. 

i. Expertise: Statistics, epidemiology & 

risk assessment. 

mstockstill on DSK4VPTVN1PROD with NOTICES

45558 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 

ii. Education: B.A. in Chemistry from 

the University of Colorado; M.D. in 

Medicine from Yale University; PhD in 

Statistics from the American University. 

iii. Professional Experience: Dr. John 

Bailar is Professor Emeritus at the 

University of Chicago and founding 

Chair of the University’s Department of 

Health Studies. His professional 

interests have centered for years on the 

causes and prevention of disease. More 

recently he has focused on improving 

quality and performance in science 

generally. He was at the U.S. National 

Cancer Institute 1956–1980, Harvard 

University 1980–1988, and McGill 

University 1988–1995, before he went to 

Chicago. At present he is Scholar in 

Residence at the National Academies. 

He was a MacArthur Fellow 1990–1995. 

He has published widely in the statistics 

and epidemiology literature, including, 

recently, the health effects of air 

pollution. His areas of expertise include 

statistics, epidemiology and risk 

assessment. He has chaired over 20 

National Academy committees and 

served on numerous others and has also 

served as monitor of more than 20 

Academy reports. 

3. Kenneth Barry Delclos, PhD, U.S. 

Food and Drug Administration (FDA), 

Jefferson, AR. 

i. Expertise: Toxicology, 

pharmacology, endocrine disruption. 

ii. Education: A.B. in Biochemistry 

from Cornell University; PhD in 

Pharmacology from Harvard University; 

Postdoctoral work at McArdle 

Laboratory for Cancer Research, 

University of Wisconsin. 

iii. Professional Experience: Dr. K. 

Barry Delclos is a Research 

Pharmacologist in the Division of 

Biochemical Toxicology at the FDA’s 

National Center for Toxicological 

Research since 1985, where he has 

conducted research in diverse areas. 

Earlier efforts focused largely on 

chemical carcinogenesis, but more 

recently his focus has been on toxicities 

associated with endocrine active agents. 

He continues to serve as Principal 

Investigator on a series of studies 

conducted under an Interagency 

Agreement between the FDA and the 

National Toxicology Program to 

evaluate aspects of the hypothesis that 

exposure to low levels of hormonally 

active agents, particularly during 

development, adversely affects human 

health, including reproductive function 

and carcinogenesis. He has served on 

interagency committees evaluating 

carcinogens and endocrine active 

agents, including several EPA advisory 

panels relating to endocrine active 

chemicals. 

4. Russell L. Carr, PhD, Mississippi 

State University, Mississippi State, MS. 

i. Expertise: Developmental 

neurotoxicology. 

ii. Education: B.S. in Biology and 

Chemistry from Delta State University; 

M.S. in Zoology and PhD in Animal 

Physiology from Mississippi State 

University; Postdoctoral work at 

Mississippi State University. 

iii. Professional Experience: Dr. 

Russell Carr is an Associate Professor in 

the Center for Environmental Health 

Sciences, in the College of Veterinary 

Medicine at Mississippi State 

University. Prior to serving in his 

current faculty position, Dr. Carr 

completed postdoctoral training (1995) 

and served as a Research Toxicologist 

(1995–1999) at Mississippi State. Dr. 

Carr’s primary research interests are in 

the area of developmental 

neurotoxicology with emphasis on 

environmental chemicals. One focus is 

investigating the mechanisms by which 

developmental organophosphorus 

insecticide exposure alters the 

neurochemistry of the brain and induces 

long-term changes in behavior. Another 

focus is the development of a short lived 

aquatic vertebrate model to study the 

lifetime effects of developmental 

exposure. Dr. Carr is currently the 

Research Coordinator/Evaluator for the 

Indianola Promise Community of the 

Delta Health Alliance. He is active in 

both the national and local chapters, the 

Society of Toxicology (SOT). Dr. Carr 

has served as an ad hoc panel member 

on several U.S. EPA FIFRA SAP’s. 

5. Marion Ehrich, PhD, VirginiaMaryland Regional College of Veterinary 

Medicine, Blacksburg, VA. 

i. Expertise: Pharmacology and 

toxicology. 

ii. Education: B.S. in Pharmacy from 

South Dakota State University; M.S. in 

Pharmacology/Toxicology from the 

University of Chicago; and PhD in 

Pharmacology/Toxicology from the 

University of Connecticut at Storrs. 

iii. Professional Experience: Dr. 

Marion Ehrich is a Professor at the 

Virginia-Maryland Regional College of 

Veterinary Medicine (VMRCVM) in 

Blacksburg, VA, and VT Carilion School 

of Medicine in Roanoke, VA. In addition 

to teaching pharmacology and 

toxicology to medical, veterinary and 

graduate students, her professional 

responsibilities include service in the 

Veterinary Medical Teaching Hospital 

Pharmacy and in the Toxicology 

Diagnostic Laboratory. She has been 

teaching at VMRCVM since 1980, when 

she also became a member of the 

Society of Toxicology (SOT) and a 

Diplomate of the American Board of 

Toxicology. She was elected a fellow of 

the Academy of Toxicological Sciences 

in 1999. Dr. Ehrich’s primary research 

activities are associated with the 

comparative neurotoxicities of 

antiesterase pesticides, with both in vivo 

and in vitro models used for study. Dr. 

Ehrich was the 2003–2004, President of 

the SOT and their 2010 Merit Awardee. 

She served as Treasurer for the Board of 

Directors of the American Board of 

Toxicology (1985–89), Secretary for the 

SOT (1992–94), and Treasurer for the 

Academy of Toxicological Sciences 

(2006–09). She has also chaired SOT’s 

Education Committee (1990–92), SOT’s 

Regulatory Affairs and Legislative 

Action Committee (1997–98), SOT’s 

Neurotoxicology Specialty Section 

(2008–2009), and the Toxicology 

Education Foundation (2000–2001). In 

addition, she served on the Executive 

Board of the Council for Scientific 

Society Presidents. She currently serves 

on the National Research Council’s 

Committee on Toxicology and editorial 

boards for the International Journal of 

Toxicology, the Journal of Applied 

Toxicology, and NeuroToxicology. 

6. Jay Gan, PhD, University of 

California, Riverside, CA. 

i. Expertise: Environmental chemistry. 

ii. Education: PhD in Pesticide 

Chemistry from Zhejiang University 

(Hangzhou, China); Postdoctoral fellow 

with IAEA’s Laboratories in Seibersdorf, 

Austria (1990–1991) and University of 

Minnesota in St. Paul, MN (1991–1993). 

iii. Professional Experience: Dr. 

Jianying (Jay) Gan is currently a 

Professor of Environmental Chemistry, 

in the Department of Environmental 

Sciences at the University of California 

(UC) Riverside, where he served as the 

Department Chair from 2007 to 2010. He 

joined the UC Riverside faculty in 2001, 

following 8 years service as a Research 

Scientist with the (USDA) Agricultural 

Research Service Laboratory in 

Riverside, CA. His research is related to 

environmental fate, transport, and risk 

assessment of pesticides, wastewater 

trace pollutants, and persistent organic 

pollutants, with an emphasis on water 

quality and risk mitigation. To date he 

has authored over 175 technical journal 

articles, and edited four pesticide books 

through American Chemical Society. Dr. 

Gan, currently supervises five PhD 

students majoring in Environmental 

Sciences or Environmental Toxicology. 

He teaches ‘‘Fate and Transport of 

Contaminants in Soil’’ to undergraduate 

students and ‘‘Environmental Organic 

Chemistry’’ to graduate students. Dr. 

Gan, was elected a Fellow of American 

Association for the Advancement of 

Science (AAAS) in 2008, a Fellow of 

American Society of Agronomy (ASA) 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 45559 

in 2006, and a Fellow of Soil Science 

Society of America (SSSA) in 2010. 

7. Ellen Gold, PhD, University of 

California Davis School of Medicine, 

Davis, CA. 

i. Expertise: Epidemiology, effects of 

environmental exposures on women’s 

health, endocrine function and 

reproductive health. 

ii. Education: B.A. in Bacteriology and 

M.A. in Zoology from the University of 

California—Los Angeles; PhD in 

Epidemiology from The Johns Hopkins 

University School of Hygiene and 

Public Health. 

iii. Professional Experience: Dr. Ellen 

Gold is the current Chair of the 

Department of Public Health Sciences 

and Chief of the Division of 

Epidemiology, in that Department in the 

University of California Davis School of 

Medicine and former Chair of the 

Graduate Group in Epidemiology. After 

receiving her PhD she became a faculty 

member at The Johns Hopkins 

University until she moved to the UC 

Davis faculty in 1988. She has been 

principal investigator on a number of 

NIH-funded, peer-reviewed grants and 

has had continuous NIH research grant 

funding for over 20 years. These 

research grants have largely focused 

over the past 30 years on lifestyle and 

environmental factors that affect 

women’s reproductive health and 

cancer risk and include her work for the 

past 15 years studying the natural 

history of the menopausal transition, 

including hormonal and symptomatic 

changes, in a longitudinal study of a 

large, multi-racial/ethnic national 

cohort. She has also authored or coauthored over 150 peer-reviewed 

publications. She has mentored 

numerous graduate students and junior 

faculty and has received a number of 

outstanding faculty and mentoring 

awards, as co-director of the UC Davis 

Building Interdisciplinary Research 

Careers in Women’s Health program and 

is a Fellow in the American Association 

for the Advancement of Science. 

8. Pertti (Bert) J. Hakkinen, PhD, 

National Institutes of Health, Bethesda, 

MD. 

i. Expertise: Toxicology. 

ii. Education: B.A. in Biochemistry 

and Molecular Biology from the 

University of California—Santa Barbara; 

PhD in Comparative Pharmacology and 

Toxicology from the University of 

California, San Francisco, CA. 

iii. Professional Experience: Dr. Pertti 

(Bert) Hakkinen is the Senior 

Toxicologist and Toxicology and 

Environmental Health Science Advisor 

in the Division of Specialized 

Information Services at the National 

Library of Medicine (NLM), National 

Institutes of Health (NIH). He provides 

leadership on the development of new 

resources in toxicology, exposure 

science, and risk assessment, and 

enhancements to existing NLM 

resources in these fields. Dr. Hakkinen 

is the project leader for the Wireless 

Information System for Emergency 

Responders (WISER) and Chemical 

Hazards Emergency Medical 

Management (CHEMM) tools, represents 

NLM on various committees, and 

provides leadership for NLM’s 

participation in national and 

international efforts in toxicology-, 

exposure-, and risk assessment-related 

information. He also is the co-director of 

a Public Health Informatics course 

offered since 2009, at the Uniformed 

Services University of the Health 

Sciences (USUHS) in Bethesda, 

Maryland, and is the vice-chair of the 

SAP for the Mickey Leland National 

Urban Air Toxics Research Center 

(NUATRC) in Houston, Texas. During 

his career, Dr. Hakkinen has held 

numerous leadership positions in the 

field of toxicology and risk assessment. 

Before joining the NIH in 2008, Dr. 

Hakkinen served for several years on the 

auxiliary staff of the European 

Commission (EC) at the EC’s Institute 

for Health and Consumer Protection, 

Joint Research Centre, in Italy. He has 

also held positions with Toxicology 

Excellence for Risk Assessment (TERA) 

and Gradient Corporation in the United 

States and at the Procter and Gamble 

Company in the United States and 

Japan. Dr. Hakkinen is a member of the 

Society of Toxicology (SOT) and a 

charter member of the Society for Risk 

Analysis (SRA) and the International 

Society of Exposure Science (ISES). He 

is a co-editor and co-author of the latest 

edition of the Encyclopedia of 

Toxicology, and of the last two editions 

of the Information Resources in 

Toxicology book. Dr. Hakkinen has 

authored and co-authored numerous 

other publications. 

9. Dale Hattis, PhD, Clark University, 

Worcester, MA. 

i. Expertise: Risk assessment 

methodology. 

ii. Education: B.A. in Biochemistry 

from the University of California, 

Berkeley, CA. PhD in Genetics from 

Stanford University. 

iii. Professional Experience: Dr. Dale 

Hattis is Research Professor with the 

George Perkins Marsh Institute at Clark 

University. For the past 35 years he has 

been engaged in the development and 

application of methodology to assess the 

health, ecological, and economic 

impacts of regulatory actions. His work 

has focused on approaches to 

incorporate inter-individual variability 

data and quantitative mechanistic 

information into risk assessments for 

both cancer and non-cancer endpoints. 

Recent research has explored PBPKbased dosimetry for chlorpyrifos based 

on observations of blood levels in 

pregnant women and their newborn 

infants, quantitative analysis of 

uncertainties for cancer and non-cancer 

health risks of dioxin, age-related 

differences in sensitivity to 

carcinogenesis and other effects, a 

taxonomy of different non-mutagenic 

modes of action for carcinogenesis with 

likely differential implications for agerelated sensitivity, PBPK modeling of 

acrylamide dose in rats and humans, 

and mechanism-based dose response 

modeling of carcinogenic effects from 

ionizing radiation. He is a leader in 

efforts to replace the current system of 

uncertainty factors with distributions 

based on empirical observations. He has 

been a member of the Environmental 

Health Committee of the EPA Science 

Advisory Board, and for several years he 

has served as a member of the FQPA 

Science Review Board. He has also 

served as a member of the National 

Research Council Committee on 

Estimating the Health-Risk-Reduction 

Benefits of Proposed Air Pollution 

Regulations. He has been a Councilor 

and is a Fellow of the Society for Risk 

Analysis. 

10. David Hawthorne, PhD, University 

of Maryland, College Park, MD. 

i. Expertise: Entomology. 

ii. Education: B.S. in Biology and 

Economics from Kent State University; 

M.S. in Entomology from North Carolina 

State University; PhD in Entomology 

from Cornell University; Postdoctoral 

training at the University of Oregon and 

Cornell University. 

iii. Professional Experience: Dr. David 

J. Hawthorne is an Associate Professor 

at the University of Maryland, College 

Park, in the Department of Entomology, 

College of Computational, Mathematical 

and Natural Sciences, where he has 

served on the faculty since 1997. At 

Cornell University, Dr. Hawthorne did 

his thesis work on insect adaptation to 

resistant crop cultivars, focusing on 

quantitative genetics approaches to 

understanding that process. His postdoctoral training was done at the 

University of Oregon and at Cornell 

University. At the University of Oregon, 

he worked on molecular genetics of 

variation in anthocyanin expression in 

maize. At Cornell he developed markers 

and populations that would result in the 

first genetic linkage map of Colorado 

potato beetle and the mapping of 

resistance in that insect to the 

insecticide esfenvalerate. The 

Hawthorne lab investigates the genetic 

mstockstill on DSK4VPTVN1PROD with NOTICES

45560 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 

and ecological factors underlying 

responses of insects to novel host plants 

and agricultural pesticides. This work 

has been applied to increase 

understanding of the processes of 

speciation and the risk assessment and 

management of pesticide responses by 

both pest and beneficial insects. Dr. 

Hawthorne has an active collaboration 

at the United States Department of 

Agriculture/Agricultural Research 

Service (USDA/ARS) at Beltsville, MD, 

on the effects of chronic exposure of 

pesticides to honey bees and on the 

effects of pesticide combinations on 

honey bee health. He has authored 21 

articles on insect molecular ecology and 

genetics, has served on several grant 

review committees for the USDA and 

the NIH, and on review panels for 

development of resistance-preventing 

strategies and re-registration of Bt corn 

for the EPA. Research in Dr. 

Hawthorne’s laboratory is currently 

funded by grants from the USDA. 

11. Lawrence Kapustka, PhD, SLR 

Consulting, Calgary, Alberta, Canada. 

i. Expertise: Environmental & 

ecological risk assessment. 

ii. Education: B.S.Ed in Biology and 

M.S. in Botany from the University of 

Nebraska; PhD Plant Physiological 

Ecology from the University of 

Oklahoma. 

iii. Professional Experience: Dr. 

Lawrence Kapustka has over 35 years of 

experience in environmental and 

ecological risk assessment. He began his 

professional career in academia with 3 

years at the University of WisconsinSuperior and 10 years at Miami 

University teaching courses, conducting 

research programs, and advising 

graduate students in a range of basic and 

applied subjects including ecology, 

forestry, plant physiology, microbial 

ecology, and environmental sciences. 

He followed that academic start to his 

career with 3 years at the EPA research 

laboratory in Corvallis, Oregon where he 

led the Plant Toxicology and Hazardous 

Waste research programs. Since 1990, 

Dr. Kapustka has worked in consulting 

firms including his own private practice 

for over 15 years. Dr. Kapustka has 

gained international recognition for his 

leadership role in advancing the 

practice of environmental risk 

assessment. His contributions have 

included the development of test 

methods used to evaluate toxicity of 

chemicals to ecological receptors and 

continual refinement of approaches to 

assess environmental risks. He has 

collaborated with clients to advance the 

state-of-the-science employed in risk 

assessments, including the use of the 

basics of systems ecology and landscape 

ecology. Most recently, Dr. Kapustka has 

been working with colleagues and 

clients to incorporate spatially-explicit 

landscape perspectives to achieve 

integrated holistic risk assessments to 

inform environmental management 

decisions. He has helped clients with 

strategic planning to address 

environmental challenges, the design of 

sampling plans to characterize baseline 

conditions, and design of monitoring 

plans to track environmental 

compliance. Dr. Kapustka has worked 

with industries, public interest groups, 

and regulators from several jurisdictions 

(Federal, state/provincial, and 

international) to develop policies and 

approaches to meet emerging concerns, 

including those in the growing field of 

nanotechnology and radiation ecology. 

He has provided litigation support 

pertaining to natural resource damage 

claims, permitting, and site 

contamination cases. Dr. Kapustka has 

been responsible for business 

development, marketing, project 

management, and general business 

operations. He volunteers as a member 

of the executive committee of the 

Calgary Chapter of Ducks Unlimited 

Canada. 

12. David J. Kent, PhD, Keller & 

Heckman LLP, Washington, DC. 

i. Expertise: Environmental risk 

assessment. 

ii. Education: B.S. in Biology from 

University of Bridgeport; M.S. in 

Environmental Science from Rutgers 

University; PhD, in Environmental 

Science and Policy from George Mason 

University. 

iii. Professional Experience: Dr. David 

Kent has 28 years of consulting 

experience, primarily in the area of 

chemical and pesticide regulation for 

both domestic and international 

companies. He assists clients in 

assessing available data, manages 

consortia, conducts environmental fate 

and transport modeling, and performs 

environmental risk assessments. Dr. 

Kent is a leader in the assessment and 

management of High Production 

Volume (HPV), Medium Production 

Volume (MPV), and Persistent 

Bioaccumulative and Toxic (PBT) 

chemicals in both the United States and 

Europe. He assesses potential risks of 

chemical and pesticide use and has 

helped companies in a wide variety of 

specialty areas, including chemicals, 

pesticides, and consumer products. Dr. 

Kent is very active in advising 

companies in how best to meet their 

obligations under the European REACH 

chemical control program, the European 

Union (EU) classification and labeling 

regulation, and the EU Biocides 

Directives and Regulation. He has also 

prepared numerous data dossiers for 

client submission to regulatory agencies, 

including proprietary reports for 

submission under REACH, FIFRA, BPD, 

TSCA, HPV, FDA, and other regulatory 

and voluntary programs. Dr. Kent is 

actively involved in and commonly 

speaks at regional, national, and 

international scientific organizations. 

He has served as president of regional 

chapters of both the Society of 

Environmental Toxicology and 

Chemistry (SETAC) and the Society for 

Risk Analysis (SRA). He chaired the 

Program Committee for the 26th Annual 

SETAC meeting and routinely 

participates at trade associationsponsored conferences, often as the 

moderator for panels. Dr. Kent has 

authored or co-authored more than 100 

scientific articles, presentations, and 

other documents for both peer-reviewed 

journals and technical newsletters. 

Topics have included preparations and 

requirements for REACH, probabilistic 

ecological risk assessment of pesticides, 

the proposed Biocide Products 

Regulation, ecological risk assessment 

for wetlands, policy implications of 

emerging chemical regulations, and the 

status and trends of the HPV Chemical 

assessment programs in the United 

States and Europe. 

13. Lynda Lanning, D.V.M., DABT, 

National Institutes of Health, Bethesda, 

MD. 

i. Expertise: Toxicology and 

pathology. 

ii. Education: B.S. in Animal Science 

and Zoology from North Carolina State 

University; D.V.M from Auburn 

University. 

iii. Professional Experience: Dr. Lynda 

Lanning is a Health Administrator in the 

Office of Regulatory Affairs, Division of 

Microbiology and Infectious Disease, 

National Institute of Allergy and 

Infectious Disease, National Institutes of 

Health. She completed a pathology 

residency at Argonne National 

Laboratory and is a Diplomate of the 

American Board of Toxicology. Her 

expertise is in toxicologic pathology, 

toxicology, safety assessment and drug 

development. Dr. Lanning’s diverse 

professional experience as a toxicologic 

pathologist includes work with the 

National Toxicology Program, medical 

device product development, contract 

research industry nonclinical 

toxicology, regulatory nonclinical 

pharmaceutical safety assessment and 

compound development, and biologic 

and therapeutic drug development of 

unique compounds for biodefense, 

global and orphan diseases. She is 

responsible for making complex 

regulatory and drug development 

recommendations based on the results 

of nonclinical studies. Dr. Lanning is 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 45561 

involved in the technical design and 

analysis of nonclinical studies for 

compounds in early and late stages of 

development, evaluation of the 

effectiveness and quality of nonclinical 

studies and safety assessment of 

compounds in development. She has 

authored numerous peer-reviewed 

publications and book chapters and is 

an active member of both national and 

international professional societies 

related to toxicology and toxicologic 

pathology. 

14. James McManaman, PhD, 

University of Colorado—Denver, 

Aurora, CO. 

i. Expertise: Biochemistry, 

neurobiology and reproductive health. 

ii. Education: B.S. in Chemistry from 

University of Northern Colorado; PhD in 

Biochemistry from University of 

Colorado—Boulder; Post Doctoral 

Fellow at Baylor College of Medicine. 

iii. Professional Experience: Dr. James 

McManaman is a Professor of Obstetrics 

and Gynecology, and Chief of the 

Division of Reproductive Sciences at the 

University of Colorado, Anschutz 

Medical Campus. He joined the 

Neurology Faculty at Baylor College of 

Medicine where he worked on 

motoneuron survival factors. Dr. 

McManaman was recruited to Synergen 

Inc., in 1992, as head of their 

Neuroscience Group. Following the sale 

of Synergen to Amgen in 1993, Dr. 

McManaman returned to academics at 

the University of Colorado’s medical 

campus where he remains. At the 

University of Colorado, Dr. McManaman 

developed active interest in mammary 

gland biology, lipid metabolism, 

preterm birth and perinatal biology, 

which are currently his primary 

research interests. Dr. McManaman is 

the Research Director of the NIH funded 

Women’s Reproductive Health Research 

Program at the University of Colorado, 

and he directs the University’s Frontiers 

in Pregnancy Research Symposia, a 

nationally recognized symposia that 

focuses on biological, psychosocial and 

clinical research related to pregnancy 

and perinatal biology. Dr. McManaman 

is also the co-director of the Adipose 

Biology Program of the University of 

Colorado’s Obesity Research Initiative. 

He has served on a number of advisory 

panels including being a regular 

member of the Integrated Clinical 

Endocrinology and Reproduction (ICER) 

Study Section at NIH from 2005–2009, 

and an ad hoc reviewer for a variety of 

other NIH Study Sections. 

15. Prakash Nagarkatti, PhD, 

University of South Carolina School of 

Medicine, Columbia, SC. 

i. Expertise: Immunotoxicology. 

ii. Education: B.Sc. in Botany and 

Chemistry and M.Sc. in Microbiology 

from Karnatak University; PhD, in 

Immunology from Jiwaji University/ 

Defense R & D Establishment, India; 

Postdoctoral research in Immunology at 

McMaster University and University of 

Kentucky School of Medicine. 

iii. Professional Experience: Dr. 

Prakash Nagarkatti is currently a South 

Carolina Distinguished Professor and 

Associate Dean for Basic Science at the 

School of Medicine, University of South 

Carolina (USC), as well as the Director 

of the NIH-supported Center of Research 

Excellence in Inflammatory and 

Autoimmune Diseases. From 2005 to 

2010, he also served as an advisor to the 

vice president for research at USC. He 

joined Virginia Tech as an assistant 

professor in 1986, and rose to become 

full professor. In 2000, Dr. Nagarkatti 

joined the Department of Pharmacology 

and Toxicology at the Medical College 

of Virginia, Virginia Commonwealth 

University as Wazeter Distinguished 

Professor and Director, 

Immunotoxicology. Dr. Nagarkatti’s 

research has been continuously 

supported by numerous grants from 

NIH, NSF/EPA, and American Cancer 

Society totaling more than $21 million. 

Currently, he serves as the Director and 

Principal Investigator on a $6 million 

NIH Interdisciplinary Center of 

Research Excellence in Inflammatory 

and Autoimmune Diseases. Dr. 

Nagarkatti has published over 150 

scientific papers in high-impact journals 

and has won numerous awards 

nationally and internationally including 

those for teaching and scholarly activity. 

He has chaired and served as a member 

on numerous NIH Study Sections and 

has been invited to give keynote/plenary 

talks at international meetings. Dr. 

Nagarkatti has also served on a number 

of advisory and review panels 

nationally and internationally, for 

Federal government and private 

foundations. Dr. Nagarkatti is one of the 

pioneers in the area of 

immunotoxicology, having published 

papers in this field from early 1980s. 

Currently, his lab has been investigating 

the effect of a wide range of 

environmental contaminants, endocrine 

disruptors, drugs, and botanicals on the 

immune response. His laboratory was 

instrumental in demonstrating for the 

first time that dioxin (TCDD) triggers 

apoptosis in immune cells through 

activation of AhR receptor. His research 

in immunotoxicology has received 

recognition and awards from the Society 

of Toxicology. More recently, Dr. 

Nagarkatti has been working on the 

impact of epigenetic regulation on the 

immune system and testing the ‘‘fetal 

basis of adult disease’’ hypothesis using 

endocrine disruptors. His research has 

provided evidence to support this 

concept by demonstrating how exposure 

to endocrine disruptors during 

pregnancy alters T cell development in 

the fetus and how this impacts the 

immune response and susceptibility to 

immunological disorders, infections and 

cancer, during adult life. 

16. Harry M. Ohlendorf, PhD, CH2M 

HILL, Inc., Sacramento, CA. 

i. Expertise: Ecological risk 

assessment & fisheries/wildlife 

ecotoxicology. 

ii. Education: B.S. in Wildlife 

Management, M.S. in Wildlife Science 

and PhD, in Wildlife Science from 

Texas A&M University. 

iii. Professional Experience: Dr. Harry 

Ohlendorf is Technology Fellow at 

CH2M Hill, Inc., and has more than 39 

years of experience in evaluating the 

impacts of environmental contaminants 

on wildlife in aquatic and terrestrial 

ecosystems, including more than 21 

years at CH2M Hill and more than 18 

years with U.S. Fish and Wildlife 

Service (USFWS). He began his career in 

1971, as a Wildlife Research Biologist 

with the USFWS Patuxent Wildlife 

Research Center, in Laurel, Maryland, 

where he served as Assistant Director 

for 7 years and remained actively 

involved in pollution ecology research. 

In 1980, he became the leader of the 

USFWS Pacific Coast Research Station 

in Davis, California, and studied the 

occurrence and impacts of contaminants 

in aquatic and terrestrial ecosystems 

until 1990 when he joined CH2M HILL. 

Dr. Ohlendorf’s experience there 

includes a wide variety of 

environmental projects, particularly 

focusing on ecological risk assessment 

and risk management, for which he 

provides firm-wide technical guidance. 

Risk assessments have focused on a 

wide range of contaminants, ecological 

receptors, and ecosystems. He is a 

Certified Wildlife Biologist and serves 

as the Chair of The Wildlife Society’s 

Wildlife Toxicology Working Group. He 

has been recognized as a ‘‘Pioneer of 

Selenium Research’’ for his extensive 

work related to selenium ecotoxicology. 

Dr. Ohlendorf served on the Editorial 

Board of the journal Environmental 

Toxicology and Chemistry in 1987– 

1989, and 2007–2010, and has authored 

more than 85 papers in the fields of 

ecotoxicology and vertebrate ecology 

(including 12 invited book chapters and 

2 books edited/co-edited). 

17. Rick Relyea, PhD, University of 

Pittsburgh, Pittsburgh, PA. 

i. Expertise: Biology, ecology and 

ecotoxicology. 

mstockstill on DSK4VPTVN1PROD with NOTICES

45562 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices 

ii. Education: B.S. in Environmental 

and Forest Biology (Wildlife 

Management) from State University of 

New York—Syracuse; M.S. in Wildlife 

Science (Wildlife Management) from 

Texas Tech University; PhD in Biology 

(Ecology, Evolution and Organismal 

Biology) from the University of 

Michigan. 

iii. Professional Experience: Dr. Rick 

A. Relyea is a Professor of Biology at the 

University of Pittsburgh and Director of 

the Pymatuning Laboratory of Ecology. 

Dr. Relyea regularly teaches courses in 

ecology, evolution, and animal behavior 

at the undergraduate and graduate 

levels. For two decades, Dr. Relyea has 

conducted research on a wide range of 

topics including community ecology, 

evolution, disease ecology, and 

ecotoxicology. He has served on 

multiple scientific panels for the NSF 

and has been an associate editor for the 

journals of the Ecological Society of 

America. He has authored more than 80 

scientific articles and book chapters, 

and has presented research seminars 

throughout the world. In 2005, he was 

named the ‘‘Chancellor’s Distinguished 

Researcher’’ at the University of 

Pittsburgh. 

18. Lee Shugart, PhD, LR Shugart & 

Associates, Inc., Oak Ridge, TN. 

i. Expertise: Biochemistry, 

environmental sciences, genetic 

ecotoxicology. 

ii. Education: B.S. in Chemistry from 

East Tennessee State University; M.S. in 

Biochemistry and PhD in Microbiology 

from the University of Tennessee. 

iii. Professional Experience: Dr. Lee 

Shugart is President of LR Shugart and 

Associates, Inc. His research interests 

are concerned with elucidating the 

cellular mechanisms of environmental 

genotoxicants and the development of 

new methodologies for quantifying the 

interaction of genotoxicants with DNA 

and proteins. He has published over one 

hundred articles in the peer-reviewed, 

scientific literature on such topics as 

protein biosynthesis, mechanisms of 

enzyme action, and nucleic acid 

biochemistry, and has conducted 

extensive research on the chemical 

modification of macromolecules by 

environmental contaminants in fish, 

rodents, and humans. He is considered 

an established authority on the use of 

the Biomarker Approach for evaluating 

the effects of contaminants on the health 

of environmental species. He is the 

current and founding Editor-in-Chief of 

the international scientific journal 

Ecotoxicology, a past member of the 

editorial board of Biomarkers and an 

Associate Editor for the 2nd edition of 

the Encyclopedia of Toxicology. He has 

served as a Consultant to the Science 

Advisory Board of the EPA and as a 

Scientific Assistant to the Deputy 

Assistant to the Secretary of Defense for 

Nuclear and Chemical and Biological 

Matters/Counter Proliferation. Dr. 

Shugart was a Line Officer in the U.S. 

Navy and served as a Communication 

Officer for the Chief of Naval Operation 

and as a Chief Engineer on a destroyer 

stationed with the 6th fleet. He is a 

veteran of the Korean Conflict. 

19. Joseph P. Sullivan, PhD, Ardea 

Consulting, Woodland, CA. 

i. Expertise: Pesticide ecotoxicology. 

ii. Education: B.A. in Biology from 

Ripon College; M.S. in Biology/Ecology 

from Utah State University; PhD in 

Wildlife Science from Virginia 

Polytechnic Institute & State University. 

iii. Professional Experience: Dr. 

Joseph Sullivan is Principal Consultant/ 

Owner of Ardea Consulting. His work 

since graduate school has involved the 

evaluation of impacts of pesticides on 

terrestrial wildlife species. His graduate 

research investigated blood biomarkers 

indicative of reproductive impacts 

following exposure to organochlorine 

insecticides. Immediately following 

graduate school, he worked for 31⁄2 years 

as the avian toxicologist for a pesticide 

manufacturing company. Dr. Sullivan 

acted as Study Director conducting EPA 

guideline ecotoxicology tests according 

to Good Laboratory Practices. He also 

spent 3 years conducting field studies 

evaluating exposure to and impacts of 

pesticides to wildlife, primarily birds. 

This experience provided in-depth 

knowledge and understanding of the 

testing necessary for the registration of 

pesticides. In 1997, he established 

Ardea Consulting which he continues to 

operate in Woodland, CA, specializing 

in avian and wildlife biology/toxicology 

as well as ecological risk assessment. In 

2009, Dr. Sullivan co-authored a chapter 

on impacts of environmental 

contaminants on wildlife in the six 

volume compendium General and 

Applied Toxicology. In Pennsylvania, he 

served as President of the Pennsylvania 

Chapter of the Wildlife Society, member 

of the Pennsylvania Biodiversity 

Partnership, and Secretary of the 

Morrisville Environmental Advisory 

Council. He has served as Treasurer, 

Secretary and Vice Chair of the Wildlife 

Toxicology Working Group of The 

Wildlife Society. Now in California, Dr. 

Sullivan serves on the Woodland Water 

Rate Advisory Committee. 

20. Vasilis Vasiliou, Ph.D., University 

of Colorado Denver, Aurora, CO. 

i. Expertise: Pharmacology & 

toxicology. 

ii. Education: B.S. in Chemistry, Ph.D. 

in Biochemistry and postdoctoral 

training in Pharmacology from 

University of Ioannina, Greece; 

Postdoctoral training in Molecular 

Toxicology from the University of 

Cincinnati. 

iii. Professional Experience: Dr. 

Vasilis Vasiliou is Professor of 

Molecular Toxicology at the 

Departments of Pharmaceutical Sciences 

and Ophthalmology at the University of 

Colorado Denver. He is also Director of 

the Toxicology Graduate Program at the 

University of Colorado Denver since 

2001, a program that has been ranked in 

the top 10 of the country. Dr. Vasiliou 

spent his one-year Sabbatical as a Guest 

Scientist at the National Eye Institute, 

National Institutes of Health (NIH 2005– 

2006) in the laboratory of Molecular and 

Developmental Biology. Dr. Vasiliou’s 

major research interest has been the 

cellular responses to oxidative stress 

induced by physical agents (e.g.. UV 

radiation), metabolism and toxicity of 

both endogenous and foreign chemicals. 

Dr. Vasiliou is a world expert in the 

Aldehyde Dehydrogenases (ALDH) and 

he maintains the official Web page for 

the ALDH superfamily. He is a 

Specialist Advisor for the Human Gene 

Nomenclature Committee of the Human 

Genome Organization (HUGO). He is a 

member of ARVO (Cornea Specialty 

Section) and Society of Toxicology 

(Ocular Toxicology & Mechanisms 

Specialty Section). Dr Vasiliou’s 

research program has been funded since 

1997, from NEI/NIH and NIAAA/NIH. 

He is the author of about 110 original 

scientific papers and review articles 

published in peer reviewed 

international journals as well as a 

number of book chapters and editorials. 

Dr. Vasiliou is the editor of the journal 

Human Genomics and he is a member 

of the Editorial Board of the Cutaneous 

and Ocular Toxicology, and The Ocular 

Surface. 

List of Subjects 

Environmental protection, Pesticides 

and pests. 

Dated: July 21, 2011. 

Frank Sanders, 

Director, Office of Science Coordination and 

Policy. 

[FR Doc. 2011–19174 Filed 7–28–11; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[FRL–9446–3] 

Proposed Consent Decree, Clean Air 

Act Citizen Suit 

AGENCY: Environmental Protection 

Agency (EPA). 

mstockstill on DSK4VPTVN1PROD with NOTICES